Glucotrack Stock Alpha and Beta Analysis
| GCTK Stock | USD 0.25 0.02 7.41% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GlucoTrack. It also helps investors analyze the systematic and unsystematic risks associated with investing in GlucoTrack over a specified time horizon. Remember, high GlucoTrack's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GlucoTrack's market risk premium analysis include:
Beta 3.02 | Alpha (2.20) | Risk 11.98 | Sharpe Ratio (0.20) | Expected Return (2.34) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
GlucoTrack |
GlucoTrack Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GlucoTrack market risk premium is the additional return an investor will receive from holding GlucoTrack long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GlucoTrack. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GlucoTrack's performance over market.| α | -2.2 | β | 3.02 |
GlucoTrack expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GlucoTrack's Buy-and-hold return. Our buy-and-hold chart shows how GlucoTrack performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.GlucoTrack Market Price Analysis
Market price analysis indicators help investors to evaluate how GlucoTrack stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlucoTrack shares will generate the highest return on investment. By understating and applying GlucoTrack stock market price indicators, traders can identify GlucoTrack position entry and exit signals to maximize returns.
GlucoTrack Return and Market Media
The median price of GlucoTrack for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 2.23 with a coefficient of variation of 34.86. The daily time series for the period is distributed with a sample standard deviation of 0.73, arithmetic mean of 2.08, and mean deviation of 0.55. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS | 09/03/2024 |
2 | Glucotrack shareholders approve pivotal issuance proposal - Investing.com | 09/26/2024 |
3 | Discretionary transaction by Darivoff Philip of tradable shares of GlucoTrack at 5.8 subject to Rule 16b-3 | 10/10/2024 |
4 | US Stocks Mixed Inflation Rate Increases In October | 11/13/2024 |
5 | Glucotrack enters material agreements following public offering | 11/19/2024 |
About GlucoTrack Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GlucoTrack or other stocks. Alpha measures the amount that position in GlucoTrack has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 1.05E-4 | 1.0E-4 | Price To Sales Ratio | 512.07 | 635.84 |
GlucoTrack Upcoming Company Events
As portrayed in its financial statements, the presentation of GlucoTrack's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GlucoTrack's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of GlucoTrack's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of GlucoTrack. Please utilize our Beneish M Score to check the likelihood of GlucoTrack's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with GlucoTrack
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out GlucoTrack Backtesting, GlucoTrack Valuation, GlucoTrack Correlation, GlucoTrack Hype Analysis, GlucoTrack Volatility, GlucoTrack History and analyze GlucoTrack Performance. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
GlucoTrack technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.